Recent Quotes (30 days)

You have no recent quotes
chg | %

Oventus Medical Ltd  

(Public, ASX:OVN)   Watch this stock  
Find more results for OVN
-0.035 (-6.25%)
Jan 19 - Close
ASX data delayed by 20 mins - Disclaimer
Currency in AUD
Range 0.52 - 0.56
52 week 0.31 - 0.80
Open 0.55
Vol / Avg. 130,715.00/179,944.00
Mkt cap 36.19M
P/E     -
Div/yield     -
EPS -0.09
Shares 90.00M
Beta     -
Inst. own     -

Key stats and ratios

Q2 (Jun '17) 2017
Net profit margin -1501.77% -1213.08%
Operating margin -1521.64% -1222.62%
EBITD margin - -1109.98%
Return on average assets -55.80% -72.95%
Return on average equity -60.81% -87.82%
CDP Score - -


+61-3-00533159 (Phone)

Website links


Oventus Medical Limited is an Australia-based medical device company that is commercializing a suite of oral appliances for the treatment of sleep apnea and snoring. The principal activities of the Company consist of the commercialization and distribution of the O2Vent Mono in Australia, as well as development of a pipeline or products to treat segments of the snoring and sleep and apnea market. These segments include those that do not comply or adhere to existing treatment options due to nasal obstruction and/or inability to utilize the continuous positive airway pressure (CPAP) mask. Its devices have an airway within the device that delivers air to the back of the mouth bypassing multiple obstructions from the nose, soft palate and tongue. The O2Vent is designed to allow nasal breathing when the nose is unobstructed. It uses three-dimensional (3D) metal printing technologies to manufacture medical devices for the treatment of sleep apnea.